Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.27
+0.5%
$3.15
$2.37
$7.63
$412.28M1.33834,383 shs376,201 shs
EXFO Inc. stock logo
EXF
EXFO
C$0.00
C$3.38
C$8.77
C$448.79MN/A25,812 shs1,106 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.23
+0.4%
$1.13
$0.92
$2.41
$465.28M1.541.93 million shs745,724 shs
Teradyne, Inc. stock logo
TER
Teradyne
$90.50
-2.7%
$85.75
$65.77
$163.21
$14.52B1.72.78 million shs2.09 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-2.99%-5.25%+0.93%-11.44%-48.66%
EXFO Inc. stock logo
EXF
EXFO
0.00%0.00%0.00%0.00%0.00%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-2.40%-6.15%+16.19%+7.96%-42.18%
Teradyne, Inc. stock logo
TER
Teradyne
-2.30%+0.88%+11.98%+30.73%-41.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
3.0416 of 5 stars
3.14.00.00.02.64.20.0
EXFO Inc. stock logo
EXF
EXFO
N/AN/AN/AN/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
3.798 of 5 stars
3.34.00.00.03.83.31.3
Teradyne, Inc. stock logo
TER
Teradyne
4.8551 of 5 stars
3.33.01.73.43.21.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.20
Hold$5.6071.52% Upside
EXFO Inc. stock logo
EXF
EXFO
0.00
N/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
2.50
Moderate Buy$2.50104.08% Upside
Teradyne, Inc. stock logo
TER
Teradyne
2.53
Moderate Buy$112.5024.32% Upside

Current Analyst Ratings Breakdown

Latest TER, LAB, EXF, and CTKB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2025
Teradyne, Inc. stock logo
TER
Teradyne
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSell$80.00
7/9/2025
Teradyne, Inc. stock logo
TER
Teradyne
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$68.00 ➝ $74.00
6/24/2025
Teradyne, Inc. stock logo
TER
Teradyne
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$90.00 ➝ $105.00
5/28/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.00
5/12/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$3.50 ➝ $3.00
5/9/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$4.00
4/30/2025
Teradyne, Inc. stock logo
TER
Teradyne
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$155.00 ➝ $133.00
4/17/2025
Teradyne, Inc. stock logo
TER
Teradyne
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$120.00 ➝ $92.00
4/17/2025
Teradyne, Inc. stock logo
TER
Teradyne
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Sector Weight
4/16/2025
Teradyne, Inc. stock logo
TER
Teradyne
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$81.00 ➝ $69.00
(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$200.45M2.06$0.03 per share96.54$3.07 per share1.06
EXFO Inc. stock logo
EXF
EXFO
C$283.98M0.00N/A36.03C$3.32 per share0.00
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$174.43M2.67N/AN/A$1.27 per share0.96
Teradyne, Inc. stock logo
TER
Teradyne
$2.82B5.15$3.76 per share24.05$17.31 per share5.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$6.02M-$0.09N/AN/A-5.71%-2.90%-2.30%8/5/2025 (Estimated)
EXFO Inc. stock logo
EXF
EXFO
N/A-C$0.14N/AN/A0.31N/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$138.88M-$0.35N/AN/AN/A-78.24%-22.44%-16.74%7/30/2025 (Estimated)
Teradyne, Inc. stock logo
TER
Teradyne
$542.37M$3.5425.5717.744.1519.86%20.06%15.23%7/23/2025 (Estimated)

Latest TER, LAB, EXF, and CTKB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.02N/AN/AN/A$46.03 millionN/A
7/30/2025Q2 2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$0.04N/AN/AN/A$39.83 millionN/A
7/23/2025Q2 2025
Teradyne, Inc. stock logo
TER
Teradyne
$0.54N/AN/AN/A$649.02 millionN/A
5/8/2025Q1 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 million
4/28/2025Q1 2025
Teradyne, Inc. stock logo
TER
Teradyne
$0.61$0.75+$0.14$0.60$680.54 million$685.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
EXFO Inc. stock logo
EXF
EXFO
N/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
Teradyne, Inc. stock logo
TER
Teradyne
$0.480.53%N/A13.56%1 Years

Latest TER, LAB, EXF, and CTKB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
Teradyne, Inc. stock logo
TER
Teradyne
quarterly$0.120.62%5/22/20255/22/20256/13/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
5.62
4.95
EXFO Inc. stock logo
EXF
EXFO
10.53
1.45
0.85
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
6.12
5.37
Teradyne, Inc. stock logo
TER
Teradyne
N/A
2.70
2.17

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
EXFO Inc. stock logo
EXF
EXFO
N/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
Teradyne, Inc. stock logo
TER
Teradyne
99.77%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.33%
EXFO Inc. stock logo
EXF
EXFO
N/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
23.16%
Teradyne, Inc. stock logo
TER
Teradyne
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500126.66 million113.58 millionOptionable
EXFO Inc. stock logo
EXF
EXFO
1,55157.46 millionN/ANot Optionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620379.82 million291.86 millionOptionable
Teradyne, Inc. stock logo
TER
Teradyne
6,500160.42 million160.16 millionOptionable

Recent News About These Companies

Why Teradyne (TER) Stock Is Trading Lower Today
Teradyne to Announce Second Quarter 2025 Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$3.26 +0.02 (+0.46%)
As of 01:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

EXFO stock logo

EXFO TSE:EXF

EXFO Inc. provides test, monitoring, and analytics solutions for fixed and mobile network operators, web-scale companies, and optical component and network equipment manufacturers in the communications industry. It offers field network testing products, such as copper/DSL testing, dispersion analysis, fiber inspection, light sources, live fiber detection, network protocol testing, optical fiber multimeter, optical loss testing, OTDR and iOLM, power meters, spectral testing, test function virtualization, test reporting and automation, and variable attenuators products, as well as modular test platforms. The company also provides lab and manufacturing testing products, including electrical BER tester/sampling oscilloscope, network protocol testing products, network simulation and load testing products, optical benchtop kits, optical communication analyzers, optical light sources, optical power meters, optical spectrum analyzers, switch and utility modules, test platforms, variable attenuators, tunable optical filters, optical component testers, and tunable laser sources; and service assurance solutions, such as service assurance and network performance monitoring, real-time active topology, network troubleshooting, geolocated RF and RAN optimization, fronthaul remote access and monitoring, remote fiber testing system, and real-time automated assurance solutions. In addition, it offers mobile portfolio that consists of network simulators and optical radio frequency test solutions for turning up and troubleshooting fiber-based mobile networks; PC-centric and open-ended platforms with cloud-based software applications; and IP assurance services, as well as monitoring services for 2G, 3G, 4G/LTE, and 5G mobile networks. The company sells products through its direct sales force, sales representatives, and distributors in the Americas, Europe, the Middle-East, Africa, and the Asia-Pacific. EXFO Inc. was founded in 1985 and is headquartered in Québec City, Canada.

Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$1.23 +0.01 (+0.41%)
As of 01:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Teradyne stock logo

Teradyne NASDAQ:TER

$90.50 -2.54 (-2.72%)
As of 01:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications. This segment also provides FLEX test platform systems; J750 test system to address the volume semiconductor devices, including microcontrollers; Magnum platform that tests memory devices, such as flash memory and DRAM; and ETS platform for semiconductor manufacturers, and assembly and test subcontractors in the analog/mixed signal markets. It serves integrated device manufacturers that integrate the fabrication of silicon wafers into their business; fabless companies that outsource the manufacturing of silicon wafers; foundries; and semiconductor assembly and test providers. The System Test segment offers defense/aerospace test instrumentation and systems; storage and system level test systems; and circuit-board test and inspection systems. The Wireless Test segment provides wireless test solutions for silicon validation, wireless module manufacturing, and wireless end device manufacturing under the LitePoint brand. This segment also offers IQxel-MX and IQxel-MW7G series products for edge measurement performance in the manufacturing of connectivity products; IQxstream-5G and IQgig-5G family products to support 4G and 5G technologies; and IQgig-UWB+ for certification and manufacturing test support for ultra wideband products. The Robotics segment provides collaborative robotic arms, autonomous mobile robots, and advanced robotic control software for manufacturing, logistics, and industrial customers. The company was incorporated in 1960 and is headquartered in North Reading, Massachusetts.